Is Prolonged Infusion of Piperacillin/Tazobactam and Meropenem in Critically Ill Patients Associated with Improved Pharmacokinetic/Pharmacodynamic and Patient Outcomes? An Observation from the Defining Antibiotic Levels in Intensive Care Unit Patients (Dali) Cohort